Results 301 to 310 of about 1,463,285 (410)

Stem Cells and Transplantation

Cancer Control, 2004
openaire   +2 more sources

GNE‐317 Reverses MSN‐Mediated Proneural‐to‐Mesenchymal Transition and Suppresses Chemoradiotherapy Resistance in Glioblastoma via PI3K/mTOR

Advanced Science, Volume 12, Issue 12, March 27, 2025.
The study identifies MSN as a key regulator of proneural‐to‐mesenchymal transition (PMT) in GSCs, driving resistance to radiotherapy (RT) and temozolomide (TMZ) in glioblastoma (GBM). However, GNE‐317 specifically inhibits MSN, reverses PMT, resensitizes cells to therapy, and shows promise as a targeted strategy to overcome chemoradiotherapy resistance
Yong‐Chang Yang, Xing‐Yu Jin, Ling‐Ling Yang, Xing Xu, Yang Xie, Yi‐Ding Ai, Xin‐Chao Li, Ye‐Cheng Ma, Cheng‐Long Xu, Qi Li, Xiang‐Lian Ge, Tai‐Long Yi, Tao Jiang, Xiao‐Guang Wang, Ying‐Zhe Piao, Xun Jin   +15 more
wiley   +1 more source

Optimal dose of bone marrow mesenchymal stem cell transplantation for experimental ulcerative colitis. [PDF]

Regen Ther
Chen X, Xia Y, Min M, Qin L, Liu Y.
europepmc   +1 more source

Mucormycosis of Petrous Bone in an Allogeneic Stem Cell Transplant Recipient [PDF]

, 1998
Maung Maung Oo, Leila A. Kutteh, Omer N. Koç, Melvin Strauss, Hillard M. Lazarus   +4 more
openalex   +1 more source

SIRT4 Promotes Pancreatic Cancer Stemness by Enhancing Histone Lactylation and Epigenetic Reprogramming Stimulated by Calcium Signaling

Advanced Science, EarlyView.
As a downstream target of α2δ1‐mediated calcium signaling, SIRT4 serves as an oncogene to promote the stemness of pancreatic cancer via deacetylating ENO1 directly at K358, leading to attenuated ENO1's RNA‐binding capacity, enhanced glycolytic substrate 2‐PG binding and robust glycolytic activity to increase the level of lactate that induce histone ...
Mengzhu Lv, Xiaodan Yang, Congcong Xu, Qingru Song, Hailian Zhao, Tianjiao Sun, Jingtao Liu, Yuan Zhang, Guogui Sun, Yuanchao Xue, Zhiqian Zhang   +10 more
wiley   +1 more source

Maintenance therapy with Azacitidine for patients with myeloid malignancies after allogeneic hematopoietic stem cell transplantation. [PDF]

Sci Rep
Lu L, Cheng Q, Yan Y, Chen X, Tang Y, Li X.   +5 more
europepmc   +1 more source

Osteoblast‐Derived Mitochondria Formulated with Cationic Liposome Guide Mesenchymal Stem Cells into Osteogenic Differentiation

Advanced Science, Volume 12, Issue 12, March 27, 2025.
This study demonstrates that the transfer of mitochondria from osteoblasts to mesenchymal stem cells (MSCs) enhances osteogenic differentiation. MSCs receiving osteoblast‐derived mitochondria exhibit increased expression of key osteogenic markers (Runt‐related transcription factor 2, RUNX2; Osterix, OSX; Osteopontin, OPN) and activate the BMP2 (Bone ...
Hye‐Ryoung Kim, Seonjeong Woo, Hui Bang Cho, Sujeong Lee, Chae Won Cho, Ji‐In Park, Seulki Youn, Gyuwon So, Sumin Kang, Sohyun Hwang, Hye Jin Kim, Keun‐Hong Park   +11 more
wiley   +1 more source

Effect of Hematopoietic Stem Cell Transplantation Regimen on Tacrolimus Pharmacokinetics. [PDF]

Curr Ther Res Clin Exp
Oku H, Yoshida S, Hotta T, Muroi H, Fukushima K, Irie K, Hirano T, Shimomura Y, Ishikawa T, Ikesue H, Muroi N, Hashida T, Sugioka N.   +12 more
europepmc   +1 more source

Machine Learning‐Enhanced Optimization for High‐Throughput Precision in Cellular Droplet Bioprinting

Advanced Science, EarlyView.
A high‐throughput droplet‐based cellular bioprinting platform enhanced with machine learning optimizes five key printing parameters—bioink viscosity, nozzle size, printing time, printing pressure, and cell concentration—to enable accurate prediction of droplet size.
Jaemyung Shin, Ryan Kang, Kinam Hyun, Zhangkang Li, Hitendra Kumar, Kangsoo Kim, Simon S. Park, Keekyoung Kim   +7 more
wiley   +1 more source

Hematopoietic stem cell transplantation for multiple sclerosis: no inflammation, no response. [PDF]

Eur J Neurol
Burt RK, Alexander T, EBMT Autoimmune Diseases Working Party (ADWP).   +2 more
europepmc   +1 more source